CardiologyNowNews.org CardiologyNowNews.org
Font ResizerAa
  • Home
    • About
      • Message from the Editor-in-Chief
      • Mission Statement
      • Editorial Board
  • News
  • Topics
    • Acute Coronary Syndrome
    • Arrhythmia and Electrophysiology
    • Cardiovascular Imaging
    • Cardiovascular Intervention
    • Cardiovascular Prevention
    • Cerebrovascular Disease
    • Heart Failure
    • Peripheral Vascular Disease
    • Structural Heart Disease
    • Valvular Heart Disease
  • Educational Resources
    • WikiDoc
    • BAIM Grand Rounds
    • Clinical Trial Results
  • ACC
    • ACC 2017
    • ACC 2018
    • ACC 2019
    • ACC 2020
    • ACC 2021
    • ACC 2022
    • ACC 2023
    • ACC 2024
    • ACC 2025
  • AHA
    • AHA 2017
    • AHA 2019
    • AHA 2021
    • AHA 2022
    • AHA 2023
    • AHA 2024
    • AHA 2025
  • ESC
    • ESC 2017
    • ESC 2018
    • ESC 2019
    • ESC 2021
    • ESC 2022
    • ESC 2023
    • ESC 2024
    • ESC 2025
  • SCAI
    • SCAI 2017
    • SCAI 2018
  • Videos
CardiologyNowNews.org CardiologyNowNews.org
Font ResizerAa
Search
  • Home
    • About
  • News
  • Topics
    • Acute Coronary Syndrome
    • Arrhythmia and Electrophysiology
    • Cardiovascular Imaging
    • Cardiovascular Intervention
    • Cardiovascular Prevention
    • Cerebrovascular Disease
    • Heart Failure
    • Peripheral Vascular Disease
    • Structural Heart Disease
    • Valvular Heart Disease
  • Educational Resources
    • WikiDoc
    • BAIM Grand Rounds
    • Clinical Trial Results
  • ACC
    • ACC 2017
    • ACC 2018
    • ACC 2019
    • ACC 2020
    • ACC 2021
    • ACC 2022
    • ACC 2023
    • ACC 2024
    • ACC 2025
  • AHA
    • AHA 2017
    • AHA 2019
    • AHA 2021
    • AHA 2022
    • AHA 2023
    • AHA 2024
    • AHA 2025
  • ESC
    • ESC 2017
    • ESC 2018
    • ESC 2019
    • ESC 2021
    • ESC 2022
    • ESC 2023
    • ESC 2024
    • ESC 2025
  • SCAI
    • SCAI 2017
    • SCAI 2018
  • Videos
Follow US
ESC 2024News

OCCUPI: Optical Coherence Tomography (OCT) Outperforms Conventional Angiography in Guiding Revascularization for Complex Coronary Lesions

Leah Kosyakovsky
Share
3 Min Read

Key Points:

  • In all-comer populations, coronary imaging guidance shows superior outcomes compared to conventional angiography in percutaneous coronary interventions (PCI).
  • The OCCUPI trial demonstrated that OCT-guided PCI significantly improved clinical outcomes over conventional angiography-guided PCI in patients with complex coronary lesions.

Previous studies have showed that imaging-guided PCI is associated with improved clinical outcomes compared to conventional angiography for treating coronary lesions. Optical coherence tomography (OCT) is a high-resolution, light-based intravascular imaging technique that allows for detailed characterization of plaque components and precise measurement of vessel and stent dimensions. Recent findings have shown that OCT guidance improves outcomes in the revascularization of complex coronary lesions, especially those at bifurcation points. Building on these findings, the OCCUPI trial was designed to test whether OCT guidance could provide superior outcomes compared to traditional angiography in patients with complex coronary lesions.

The results of the OCCUPI trial were presented by Professor Byeong-Keuk Kim from Yonsei University Severance Hospital in Seoul, Korea, at a Hotline session during ESC 2024 in London, with simultaneous publication in The Lancet. In this study, 1,604 patients were randomized in a 1:1 fashion to undergo either OCT-guided or angiography-guided PCI. The primary outcome was a composite of cardiac death, myocardial infarction (MI), stent thrombosis, and target-vessel revascularization at 1 year. Nearly all participants completed the 1-year follow-up.

The trial results showed that the OCT-guided PCI group experienced a significantly lower rate of the primary composite endpoint compared to the angiography-guided group (4.6% vs. 7.4%) over a 1-year follow-up. Additionally, fewer spontaneous MI and target-vessel revascularization events occurred in the OCT-guided group than in the angiography-guided group. Of note, the incidence of contrast-induced nephropathy was similar between the two groups.

Discussing the trial’s implications, Professor Kim stated, “Our findings provide strong evidence that OCT-guided PCI offers substantial benefits for patients with complex coronary lesions compared to conventional angiography guidance.” He added, “The next step is to establish detailed standards for the optimal use of OCT to further enhance the clinical outcomes of PCI in complex cases, based on the findings of the OCCUPI trial.”

 

TAGGED:ConferenceESC 2024FeaturedNews
Share This Article
Copy Link Print
CardiologyNowNews.org CardiologyNowNews.org
Copyright - CardiologyNowNews
  • Contact Us
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?